These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9168437)

  • 21. Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxylphenyl)-retinamide.
    Dietze EC; Yee L; Seewaldt VL
    Breast Cancer Res Treat; 2001 Mar; 66(1):41-50. PubMed ID: 11368409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N; Sausville EA; Breitman TR
    Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes.
    O'Donnell PH; Guo WX; Reynolds CP; Maurer BJ
    Leukemia; 2002 May; 16(5):902-10. PubMed ID: 11986953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells.
    Wang TT; Phang JM
    Cancer Lett; 1996 Oct; 107(1):65-71. PubMed ID: 8913268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.
    Anding AL; Jones JD; Newton MA; Curley RW; Clagett-Dame M
    Anticancer Res; 2018 Aug; 38(8):4403-4416. PubMed ID: 30061204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines.
    Merritt G; Aliprandis ET; Prada F; Rigas B; Kashfi K
    Cancer Lett; 2001 Mar; 164(1):15-23. PubMed ID: 11166911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells.
    Han HS; Kwon YJ; Park SH; Kim EJ; Rho YS; Sin HS; Um SJ
    Int J Cancer; 2004 Mar; 109(1):58-64. PubMed ID: 14735468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
    Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
    BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.
    Clifford JL; Sabichi AL; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):391-5. PubMed ID: 11319181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoma cell lines resistant for growth inhibition and apoptosis to retinoic acid are responsive to 4-hydroxy-phenyl-retinamide: correlation with tissue transglutaminase.
    Chiantore MV; Giandomenico V; De Luca LM
    Biochem Biophys Res Commun; 1999 Jan; 254(3):636-41. PubMed ID: 9920792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production.
    Simeone AM; Broemeling LD; Rosenblum J; Tari AM
    Oncogene; 2003 Oct; 22(43):6739-47. PubMed ID: 14555987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
    Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
    Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
    Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanisms of fenretinide-triggered apoptosis in leukemic cells].
    Xiao DK; Du YZ; Fan HY; Chen YL; Chen Z; Zhang J; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):975-8. PubMed ID: 16403262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways.
    Adachi H; Adams A; Hughes FM; Zhang J; Cidlowski JA; Jetten AM
    Cell Death Differ; 1998 Nov; 5(11):973-83. PubMed ID: 9846184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).
    Webber MM; Bello-DeOcampo D; Quader S; Deocampo ND; Metcalfe WS; Sharp RM
    Clin Exp Metastasis; 1999 May; 17(3):255-63. PubMed ID: 10432011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells.
    Hsieh TC; Ng C; Wu JM
    Biochem Mol Biol Int; 1995 Oct; 37(3):499-506. PubMed ID: 8595390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells.
    Um SJ; Lee SY; Kim EJ; Han HS; Koh YM; Hong KJ; Sin HS; Park JS
    Cancer Lett; 2001 Dec; 174(2):127-34. PubMed ID: 11689287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of ceramide generation and metabolism in response to fenretinide--Diversity within and among leukemia.
    Morad SA; Davis TS; Kester M; Loughran TP; Cabot MC
    Leuk Res; 2015 Oct; 39(10):1071-8. PubMed ID: 26220867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retinoic acid resistant HL-60 cell clone sensitive to N-(4-hydroxyphenyl) retinamide-mediated clonal growth inhibition.
    Brigati C; Ferrari N; Megna M; Roncella S; Cutrona G; Tosetti F; Vidali G
    Leuk Lymphoma; 1995 Mar; 17(1-2):175-80. PubMed ID: 7773156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.